scispace - formally typeset
Search or ask a question
Author

Beatriz S. Parajón-Costa

Bio: Beatriz S. Parajón-Costa is an academic researcher from National University of La Plata. The author has contributed to research in topics: Crystal structure & Cyclic voltammetry. The author has an hindex of 17, co-authored 53 publications receiving 875 citations. Previous affiliations of Beatriz S. Parajón-Costa include National Scientific and Technical Research Council.


Papers
More filters
Journal ArticleDOI
TL;DR: In this article, the mixed cation diphosphates of composition M I Fe III P 2 O 7 have been prepared using the so-called co-precipitation method starting with Fe(III) and M(I) nitrate solutions and solid (NH 4 )H 2 PO 4, and characterized by X-ray powder diffractometry.

22 citations

Journal ArticleDOI
TL;DR: In this paper, the potassium salt of the Schiff base obtained by condensation of 2-hydroxy-3methoxybenzaldehyde (o-vanillin) and 2-aminoethanesulfonic acid (taurine) in a methanol potassium hydroxide solution was characterized by crystallographic, spectroscopic and DFT methods.
Abstract: The potassium salt of the Schiff base obtained by condensation of 2-hydroxy-3-methoxybenzaldehyde (o-vanillin) and 2-aminoethanesulfonic acid (taurine) in a methanol potassium hydroxide solution was characterized by crystallographic, spectroscopic and DFT methods. The compound crystallizes in the monoclinic C2/c space group with a = 37.539(4), b = 5.9129(4), c = 26.321(5) A, β = 121.10(2)° and Z = 8 molecules per unit cell. The crystallographic data reveal that two different anionic molecules, which constitute a tautomeric pair, coexist in the crystal. This finding is supported by FTIR, Raman and electronic measurements in methanol solution. The main crystallographic differences between the bonding structures occur along the shortest chemical path linking the oxygen and the nitrogen atom of the OH and CN group. Both tautomeric forms are stabilized by strong O–H⋯N and N–H⋯O intramolecular hydrogen bonds. Optimized geometrical parameters and calculated spectroscopic features obtained by DFT calculations show a very good agreement with the experimental data. Moreover, 1H NMR, 13C NMR and electronic measurements in DMSO solution show the prevalence of the enol-imine tautomer in this solvent.

20 citations

Journal ArticleDOI
TL;DR: The new vanadyl complex and VO(L)2 complexes showed excellent selective cytotoxicity in hypoxia, being no cytotoxic in oxia, and could be indicative that complexation of the quinoxaline-2-carbonitrile N1,N4-dioxide derivatives with vanadium could improve their bioavailability.

20 citations

Journal ArticleDOI
TL;DR: The oxovanadium(IV) complex of oxodiacetic acid (H2ODA) and o-phenanthroline of stoichiometry [VO(ODA)(ophen)]⋅1.5H2O, which presents the interesting tridentate OOO coordination, was thoroughly characterized by infrared, Raman, and electronic spectroscopies.
Abstract: The oxovanadium(IV) complex of oxodiacetic acid (H2ODA) and o-phenanthroline of stoichiometry [VO(ODA)(ophen)]⋅1.5H2O, which presents the interesting tridentate OOO coordination, was thoroughly characterized by infrared, Raman, and electronic spectroscopies. The biological activity of the complex on the cell proliferation was tested on osteoblast-like cells (MC3T3E1 osteoblastic mouse calvaria-derived cells and UMR106 rat osteosarcoma-derived cells) in culture. The complex caused inhibition of cellular proliferation in both osteoblast cell lines in culture, but the cytotoxicity was stronger in the normal (MC3T3E1) than in the tumoral (UMR106) osteoblasts.

17 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: Ruthenium-based anticancer chemotherapies are making significant advances in clinical trials as discussed by the authors. But the focus has been on coordination complexes, and mechanisms such as "activation by reduction" and "transferrin-targeted delivery" have been proposed to account for the excellent cytotoxicity and low general toxicity of these complexes.
Abstract: Ruthenium-based anticancer chemotherapies are making significant advances in clinical trials. Until recently, the focus has been on coordination complexes, and mechanisms such as "activation by reduction" and "transferrin-targeted delivery" have been proposed to account for the excellent cytotoxicity and low general toxicity of these complexes. More recently organoruthenium compounds, which to some extent appear not to follow the established rules, have started to be investigated. Despite such differences, similar activities between certain coordination and organometallic compounds suggest similar modes of action are present. DNA, the classic target, is believed to be the dominant mechanism for cytotoxicity with certain ruthenium drugs, while with others, non-classical targets are thought to be more important. In this article we describe these features and show how both ruthenium coordination complexes and organoruthenium compounds represent an ideal scaffold for further drug design and optimisation.

572 citations

Journal ArticleDOI
TL;DR: If the potential opportunities of the Cu-NSAIDs are to be completely realized, a mechanistic understanding and delineation of their in vivo and in vitro pharmacological activity is fundamental, along with further characterization of their pharmacokinetic/pharmacodynamic disposition.

482 citations

Journal ArticleDOI
TL;DR: This review provides an overview of metal-based anticancer drugs and drug candidates, focusing on metal complexes that can be activated in the reducing environment of cancer cells, thus serving as prodrugs.

430 citations

Journal ArticleDOI
TL;DR: In this article, the authors discuss the modes of coordination of oligopeptides by Cu(II) and Ni(II), and special attention is given to two general classes of peptides.

411 citations

Journal ArticleDOI
TL;DR: This work reviews the medicinal applications proposed for vanadium compounds with particular emphasis on the more recent publications and concludes that the potential ofVanadium compounds to treat type 2 diabetes is still an open question and therapies using vanadium compound for e.g. antitumor and anti-parasitic related diseases remain promising.

373 citations